Myasthenia Gravis
📧 Sign up to get email alerts when something new happens for Myasthenia Gravis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-21EMA Authorised: Imaavy (nipocalimab) — Janssen Cilag International NV
EMA has authorised Imaavy (nipocalimab) for myasthenia gravis, with Janssen Cilag International NV as the marketing authorization holder.
-
EMA approval · 2026-08-21EMA Authorised: Rystiggo (rozanolixizumab) — UCB Pharma
Rystiggo (rozanolixizumab) has been authorised in the EU for myasthenia gravis by UCB Pharma.
-
EMA approval · 2026-08-21EMA Authorised: Zilbrysq (zilucoplan) — UCB Pharma S.A.
Zilbrysq (zilucoplan) has been authorised by the EMA for use in myasthenia gravis.
-
CLINICAL_TRIALS trial_result · 2026-06-18Clinical Trial Results: Disease-Modifying Treatments for Myasthenia Gravis
Completed clinical trial evaluating disease-modifying treatments for myasthenia gravis; results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-28Clinical Trial Update: Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis [Phase 3]
A Phase 3 clinical trial update reports on the safety of HBM9161 (HL161) administered subcutaneously in patients with generalized myasthenia…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2026-04-23EMA Authorised: Zilbrysq (zilucoplan) — UCB Pharma S.A.
The EMA authorised Zilbrysq (zilucoplan) from UCB Pharma S.A. for the treatment of myasthenia gravis. This marks regulatory approval for thi…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
ADAPT Forward is a master protocol platform study sponsored by argenx to evaluate the safety and efficacy of multiple regimens in participan…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod [Phase 2]
Phase 2 trial ADAPT Forward 1 evaluating Empasiprubart IV as add-on therapy to Efgartigimod IV in AChR-Ab seropositive generalized Myastheni…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases [Phase 1]
A Phase 1 trial evaluating the safety and preliminary efficacy of KITE-363 in relapsed/refractory autoimmune neurologic diseases is currentl…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis [Phase 2]
Phase 2 study evaluating povetacicept in adults with generalized myasthenia gravis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria. [NA]
A completed Damascus University trial compared intravenous immunoglobulin (IVIG) to plasmapheresis (PLEX) for myasthenic crisis/myasthenia g…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis [Phase 2]
The document describes a Phase 2 clinical trial assessing three dose levels of NMD670 in adults with myasthenia gravis (including MuSK-posit…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis [Phase 3]
This clinical trial update describes a Phase 3 study comparing Nipocalimab and Efgartigimod for generalized myasthenia gravis, sponsored by …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases. [Phase 1]
Phase 1 clinical trial update assessing the safety and pharmacodynamics of QH103 cell injections in relapsed/refractory antibody-mediated ne…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: TCM Tongue Diagnosis and Syndrome Differentiation in Myasthenia Gravis Compared to Healthy Controls [NA]
A study examining traditional Chinese medicine tongue diagnosis and syndrome differentiation in people with myasthenia gravis vs healthy con…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Talquetamab in Patients With Refractory Generalized Myasthenia Gravis [NA]
A clinical trial update indicates talquetamab is being studied in patients with refractory generalized myasthenia gravis, with the study not…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis [Phase 2, Phase 3]
Kyverna Therapeutics' KYSA-6 anti-CD19 CAR-T therapy is being evaluated in Phase 2/3 trials for generalized myasthenia gravis, with recruitm…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: The Effectiveness of an ETP Programme in Myasthenia Gravis: a Proof-of-concept Study.
A proof-of-concept clinical trial is evaluating the effectiveness of an exercise therapy program for Myasthenia Gravis; the study is current…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of rozanolixizumab in adult Chinese participants with generalized myasthenia gravi…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis [Phase 3]
A Phase 3 clinical trial update for Descartes-08, an mRNA CAR T-cell therapy, evaluating its use in myasthenia gravis and currently recruiti…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis [NA]
This clinical trial is evaluating the effects of light versus moderate intensity exercise in people with myasthenia gravis and is currently …
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG) [NA]
A clinical trial is evaluating the efficacy and safety of HN2302 for refractory myasthenia gravis. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease [NA]
A clinical trial is evaluating the effects of whole-body electrical muscle stimulation on adults with various neuromuscular diseases and is …
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Long-term Efficacy of Modified Guilu Erxian Glue for Myasthenia Gravis
This document reports on the completion and long-term efficacy data from a clinical trial evaluating Modified Guilu Erxian Glue for Myasthen…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Study in Patients With Myasthenia Gravis in China
A clinical trial in China studying Myasthenia Gravis sponsored by AstraZeneca is currently active but not recruiting.